Wall Street Analysts See 33.38% Upside in LifeStance Health, Despite Optimism Being Questionable

Wall Street analysts see a 33.38% upside in LifeStance Health (LFST) stock, with a mean price target of $8.63. While this indicates potential growth, investors should be aware that analysts' price targets are not always reliable and can be influenced by business incentives. The stock has gained 27.1% over the past four weeks and closed at $6.47.